Exact Sciences ($EXAS) SVP Sells $90,000 Worth of Company Stock
EXACT SCIENCES CORP
Subscribe to track EXAS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Exact Sciences ($EXAS) SVP Sells $90,000 in Stock
Company: EXACT SCIENCES CORP (EXAS) Form: 4 | Filed: 2025-10-10 Significance: Low
Insider: Herriott James Title: SVP, General Counsel & Sec | Relationship: Officer
Transaction: • Type: Sell • Shares: 1,500 • Price: $60.00 • Value: $90,000 • Owned After: 14,085 (Direct)
Key Insight: This sale was conducted under a pre-arranged Rule 10b5-1 trading plan established in March 2025, which significantly reduces its importance as an indicator of insider sentiment.
Market Context: Pre-planned sales are common for executives for personal financial planning and are not typically viewed as a bearish signal for the company's outlook.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EXACT SCIENCES CORP (EXAS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A company executive sold $90,000 worth of stock as part of a pre-scheduled Rule 10b5-1 trading plan, indicating a routine liquidity event rather than a change in outlook.
- Market Impact: The impact on the stock is expected to be neutral, as sales under 10b5-1 plans are disclosed in advance and are not considered spontaneous trading decisions based on new information.
Company Information
| Field | Value |
|---|---|
| Company | EXACT SCIENCES CORP |
| Ticker Symbol | EXAS |
| CIK | 0001124140 |
| Industry | SERVICES-MEDICAL LABORATORIES [8071] |
Insider Information
| Field | Value |
|---|---|
| Name | Herriott James |
| CIK | 0001957680 |
| Title/Position | SVP, General Counsel & Sec |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-09 |
| Transaction Code | S (Open market or private sale of securities) |
| Security Type | Common Stock |
| Shares Involved | 1,500 |
| Price Per Share | $60.00 |
| Total Value | $90,000.00 |
| Shares Owned After | 14,085 (Directly) |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction was executed under a Rule 10b5-1 trading plan, which was established on March 3, 2025. This removes the element of surprise and implies the sale was not based on recent non-public information. Such pre-planned sales are common for executive compensation and diversification.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size of 1,500 shares is unlikely to significantly affect the daily trading volume of EXAS.
- Sentiment Indicator: Neutral. The market generally discounts the informational value of 10b5-1 plan sales.
Investment Insights
Positive Market Indicators
- The insider continues to hold a substantial position in the company post-transaction, with 15,641 shares held directly and indirectly, in addition to 37,434 in options and RSUs.
Risk Factors
- While this specific sale is low-significance, a pattern of continued sales by multiple insiders could be a point of concern for investors to monitor over time.
Key Takeaways
- Pre-Planned Sale: The sale is not opportunistic but a scheduled event under a 10b5-1 plan, making it a poor gauge of the insider's current sentiment.
- Moderate Value: The total value of $90,000 is not substantial for a Senior Vice President, reinforcing the idea of a routine personal finance transaction.
- Continued Ownership: The insider maintains a significant stake in the company, aligning their interests with shareholders.
Contextual Analysis
Timing Significance
The trading plan was established in March 2025, well before the transaction date in October 2025. This long lead time confirms the pre-planned nature of the sale.
Transaction Context
Footnote 1 explicitly states the transaction was made pursuant to a Rule 10b5-1 trading plan. This is a critical piece of context that mitigates the negative signal a typical insider sale might send.
Company Context
This analysis is based solely on the content of the Form 4 filing. For a complete picture, this data should be correlated with recent company news, earnings reports, and overall market and sector performance.
Risk Assessment
Risk Level: Low
Risk Factors
- Misinterpretation: The primary risk is that market participants might misinterpret this as a bearish signal without noting the 10b5-1 plan context.
- Personal Liquidity Needs: The sale is most likely driven by the insider's personal financial planning (e.g., diversification, tax obligations) rather than a negative view of the company's future.
Market Considerations
- Transparency: The SEC requires disclosure of 10b5-1 plans, allowing the market to properly contextualize such trades.
- Focus on Buys: The market typically places much higher significance on insider buys, as they are a stronger signal of confidence than sales are of a lack of confidence.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.